| |
| |
|
| Insider
Information: |
Sherman Matthew L |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
197,506 |
|
|
Indirect Shares
|
8,500 |
|
|
| Direct
Value |
$15,072,557 |
|
|
|
Indirect Value
|
$1,519,375 |
|
|
| Total
Shares |
206,006 |
|
|
| Total
Value |
$16,591,932 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.6
|
| Percentage
Gain/Loss : |
0.0%
|
 377.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
EVP & Chief Medical Of... |
2018-04-03 |
68,767 |
2018-04-03 |
8,500 |
Premium* |
|
|
Pulmatrix Inc |
PULM |
Director |
2018-04-03 |
20,000 |
2018-04-03 |
0 |
Premium* |
|
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
|
2024-02-16 |
108,739 |
2019-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-08-18 |
4 |
OE |
$0.48 |
$10,048 |
D/D |
5,600 |
33,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-08-24 |
4 |
OE |
$3.88 |
$77,600 |
D/D |
20,000 |
52,004 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
46,000 |
98,004 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-09-16 |
4 |
AS |
$34.96 |
$13,984 |
I/I |
(400) |
9,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-09-16 |
4 |
AS |
$32.22 |
$52,493 |
D/D |
(1,600) |
96,404 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-10-15 |
4 |
AS |
$22.69 |
$27,853 |
I/I |
(1,200) |
8,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2015-10-15 |
4 |
AS |
$22.66 |
$111,816 |
D/D |
(4,800) |
91,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
97,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-04-06 |
4 |
AS |
$32.00 |
$66,560 |
D/D |
(2,080) |
95,524 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-04-07 |
4 |
AS |
$32.00 |
$765,440 |
D/D |
(23,920) |
85,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-04-07 |
4 |
OE |
$5.08 |
$71,120 |
D/D |
14,000 |
109,524 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-07-01 |
4 |
AS |
$34.20 |
$903,143 |
D/D |
(26,000) |
73,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-07-01 |
4 |
OE |
$3.88 |
$67,841 |
D/D |
14,000 |
99,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-07-07 |
4 |
OE |
$5.28 |
$31,680 |
D/D |
6,000 |
79,604 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2016-08-10 |
4 |
OE |
$5.28 |
$131,051 |
D/D |
18,896 |
98,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2017-01-04 |
4 |
AS |
$26.81 |
$54,916 |
D/D |
(2,000) |
96,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,900 |
104,400 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2017-07-05 |
4 |
AS |
$32.00 |
$512,000 |
D/D |
(16,000) |
96,400 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2017-07-05 |
4 |
OE |
$7.12 |
$56,960 |
D/D |
8,000 |
112,400 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2017-09-12 |
4 |
AS |
$38.32 |
$706,799 |
D/D |
(18,400) |
78,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2018-01-03 |
4 |
AS |
$40.86 |
$197,868 |
D/D |
(4,633) |
73,367 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP & Chief Medical Officer |
• – – |
2018-04-03 |
4 |
AS |
$38.28 |
$176,772 |
D/D |
(4,600) |
68,767 |
0 |
- |
|
122 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
